Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide
Background: Glioblastoma (GBM) prognosis remains extremely poor despite standard treatment that includes temozolomide (TMZ) chemotherapy. To discover new GBM drug targets and biomarkers, genes signatures associated with survival and TMZ resistance in GBM patients treated with TMZ were identified.Met...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2023-12-01
|
| Sarja: | Frontiers in Genetics |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1320789/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|